Clinical Trial Update: Crossover Trial for Nicotinamide Riboside in Subjective Cognitive Decline and Mild Cognitive Impairment [NA]

View source ↗

Summary

The document reports the completion and posting of results for a crossover trial of nicotinamide riboside in individuals with subjective cognitive decline and m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Subjective Cognitive Decline

Drugs mentioned

• Nicotinamide Riboside (nicotinamide riboside)

Snippet

Sponsor: Steven E Arnold, MD | Conditions: Cognition Disorders in Old Age, Mild Cognitive Impairment | NA | Status: COMPLETED | Results posted: 2024-11-29